Who will be the first to take advantage of the vaccine against David-19?

If a safe and effective vaccine finally comes up against COVID-19, the disease that is taking thousands of lives worldwide, who will be the first to benefit it? Well, of course, it'll be the people in the country where the vaccine was made. About a dozen vaccines are currently [...]
Well, of course, it'll be the people in the country where the vaccine was made.
About a dozen vaccines are currently in different stages of worldwide testing, including in Britain, Russia, China and the US.
This week, Dr. Anthony Fauci, U.S. best infectious disease expert, said he is optimistic that there will be a vaccine against him COVID 19 by the end of the year or early 2021.
Some wealthy countries have ordered millions of doses of experimental vaccines so far.
Britain and the United States, for example, have invested in a type of vaccine that is being tested by Oxford University and produced by Astra-Zeneca.
If it works, American politicians have said that even the British will be vaccinated with it.
The U.S.A. expects to begin collecting it in the autumn, but they have also invested in other vaccine alternatives.
Groups involving the type of GAVI vaccines are also working to buy poor countries to buy vaccine doses, and AstraZeneca has agreed to licensed her vaccine near the “Serum” in India for the production of 1 billion doses.
The World Health Organisation (OBSH) is drafting guidelines for the ethical distribution of COVID-19 vaccines.
But the way vaccines are distributed within a country will change. Last week, US officials said they were establishing a level system for this. The system will likely determine the priorities of groups at greater risk by COVID-19, but also for first-line employees. Furthermore, the vaccine will be distributed to other groups.











